InflaRx NV (IFRX)
2.06
+0.02
(+0.98%)
USD |
NASDAQ |
Nov 21, 16:00
2.10
+0.04
(+1.94%)
After-Hours: 20:00
InflaRx Profit Margin (Quarterly): -14.09K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -14.09K% |
| June 30, 2024 | -217.8K% |
| March 31, 2024 | -26.80K% |
| Date | Value |
|---|---|
| December 31, 2023 | -696.8K% |
| September 30, 2023 | -12.26K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-696.8K%
Minimum
Dec 2023
-12.26K%
Maximum
Sep 2023
-193.6K%
Average
-26.80K%
Median
Mar 2024
Profit Margin (Quarterly) Benchmarks
| Affimed NV | -9.77K% |
| BioNTech SE | 15.91% |
| Immatics NV | -16.95% |
| CureVac NV | 68.44% |
| ATAI Life Sciences NV | -65.72K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -61.55% |
| Return on Assets | -53.75% |
| Return on Invested Capital | -61.55% |
| Operating Margin (Quarterly) | -12.41K% |
| Return on Net Operating Assets | -227.6% |